Compare BROS & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BROS | CAI |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.0B |
| IPO Year | 2021 | N/A |
| Metric | BROS | CAI |
|---|---|---|
| Price | $50.71 | $18.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 9 |
| Target Price | ★ $77.33 | $32.78 |
| AVG Volume (30 Days) | ★ 4.0M | 2.0M |
| Earning Date | 05-06-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.24 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $1,638,159,000.00 | N/A |
| Revenue This Year | $27.34 | $24.26 |
| Revenue Next Year | $23.20 | $22.60 |
| P/E Ratio | $79.96 | ★ N/A |
| Revenue Growth | ★ 27.88 | N/A |
| 52 Week Low | $46.52 | $17.15 |
| 52 Week High | $77.88 | $42.50 |
| Indicator | BROS | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.41 | 42.97 |
| Support Level | $50.11 | $17.33 |
| Resistance Level | $59.82 | $21.47 |
| Average True Range (ATR) | 2.30 | 0.99 |
| MACD | 0.15 | 0.19 |
| Stochastic Oscillator | 47.94 | 37.35 |
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies, and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company-operated shops.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.